| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 21 May 2026 | 14 May 2026 |
| Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the half year and financial year ended March 31 2026. Outcome of the Board Meeting held on May 21, 2026 (As Per BSE Announcement Dated on 21.05.2026) | ||
| Board Meeting | 7 Nov 2025 | 3 Nov 2025 |
| Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the half year ended on September 30 2025 Outcome of the Board Meeting pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 held on Friday, November 07, 2025 (As Per BSE Announcement Dated on 07.11.2025) | ||
| Board Meeting | 20 Aug 2025 | 20 Aug 2025 |
| Outcome of the Board Meeting held on Wednesday, August 20, 2025 | ||
| Board Meeting | 17 Jul 2025 | 17 Jul 2025 |
| Allotment of 10,75,000 Equity shares consequent to conversion of Convertible Warrants | ||
| Board Meeting | 1 Jul 2025 | 1 Jul 2025 |
| Appointment of the Company Secretary and Compliance Officer of the Company | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.